Efficacy and safety of everolimus plus exemestane in patients with HR+, HER2- advanced breast cancer progressing on/after prior endocrine therapy in routine clinical practice: Primary results from the non-interventional study, STEPAUT.

Steger, Guenther G, Egle, Daniel, Bartsch, Rupert, Pfeiler, Georg, Petru, Edgar, Greil, Richard, Helfgott, Ruth, Marth, Christian, Öhler, Leopold, Hubalek, Michael, Lang, Alois, Tinchon, Christoph, Haslbauer, Ferdinand, Redl, Andreas, Hock, Karin, Hennebelle, Mathias, Mraz, Bernhard and Gnant, Michael (2020) Efficacy and safety of everolimus plus exemestane in patients with HR+, HER2- advanced breast cancer progressing on/after prior endocrine therapy in routine clinical practice: Primary results from the non-interventional study, STEPAUT. Breast (Edinburgh, Scotland), 50. pp. 64-70. ISSN 1532-3080

Full text not available from this repository.

Item Type:	Fachpublikation (peer reviewed)
Divisions:	Ordensklinikum Linz Barmherzige Schwestern > Allgemeinchirurgie mit Viszeralchirurgie
Depositing User:	Prof. Reinhold Fuegger
Date Deposited:	03 Feb 2021 09:02
Last Modified:	17 Feb 2025 09:33
URI:	https://eprints.vinzenzgruppe.at/id/eprint/9100

Edit Item